Navigation Links
Fetal alcohol syndrome testing expands

Kingston, ON Improved technology, partnerships and collaboration across two provinces have allowed Queen's University scientists to dramatically expand the use of eye-movement tests that help identify and assess children with Fetal Alcohol Spectrum Disorder (FASD).

"Our initial study was carried out with a relatively small group of children who had to travel to Queen's to participate in the experiment," notes Pharmacology and Toxicology professor James Reynolds, who leads the project. "Establishing a mobile laboratory allowed us to go where the kids are, and carry out these experiments in community settings."

Thanks to the cooperation of local health professionals and community members, the researchers tested more than 200 children in nine different Ontario and Alberta locations.

"Now we know that the results of eye movement testing are consistent across different geographical locations something that is absolutely critical if this type of testing is to be widely applicable," says Dr. Reynolds.

Until now, there have been few objective tools that will accurately measure brain function in young children. This breakthrough will add eye movement testing to the standard clinical assessment protocols currently in use, to determine the potential for identifying at-risk children.

The work was sponsored by the Canadian Institutes of Health Research (CIHR) as part of a multi-university New Emerging Team project. The findings are highlighted today in an on-line article in the European Journal of Neuroscience.

"This is a most original finding, with clear clinical application," says Dr. Rmi Quirion, Scientific Director of the CIHR Institute of Neurosciences, Mental Health and Addiction. "Fetal Alcohol Spectrum Disorder is a significant health issue in Canada. The work of Dr Reynolds and his team is an excellent example of what CIHR aims for: improving the health of Canadians through cutting-edge, innovative research."

The Queen's researchers are continuing to develop novel approaches for using eye movements to assess brain function. In collaboration with Doug Munoz, director of Queen's Centre for Neuroscience Studies, they are using the university's functional MRI (magnetic resonance imaging) facility to measure differences in brain activity in children with developmental disorders such as FASD and ADHD (Attention Deficit Hyperactivity Disorder). They are building a database of task performance and brain functioning across many clinical populations.

"This is very exciting because it points us toward using eye movements to show differences in clinical populations," says Dr. Reynolds. "Once we understand what 'typical' development looks like, we can use the same tools to identify signature characteristics of each of the disorders."

Defined as birth defects resulting from a mother's consumption of alcohol during pregnancy, FASD is believed to affect approximately one per cent of children in Canada. FASD is associated with hyperactivity, difficulty in learning, and deficits in memory, understanding and reasoning, as well as problems dealing with stress.

In the absence of confirmed maternal alcohol consumption during pregnancy, the diagnosis of FASD remains a significant clinical challenge. "The ability to objectively assess brain function at earlier and earlier ages will be hugely beneficial in the long term, because it will help identify the at-risk children for whom targeted interventions will have the greatest impact," says Dr. Reynolds.


Contact: Nancy Dorrance
Queen's University

Related biology news :

1. Chicks to give scientists clearer picture of fetal development
2. Alcohol consumption can cause too much cell death, fetal abnormalities
3. Researchers block damage to fetal brain following maternal alcohol consumption
4. New study shows that fetal cells to treat Parkinsons disease may not function long term
5. Study suggests new way to screen infants for fetal alcohol syndrome
6. Study reveals possible genetic risk for fetal alcohol disorders
7. AJCN study shows moderate alcohol consumption related to stronger bones
8. Moderate alcohol intake associated with bone protection
9. Alcohol: A life sentence
10. Resveratrol prevents fat accumulation in livers of alcoholic mice
11. Alcohol binges early in pregnancy increase risk of infant oral clefts
Post Your Comments:
Related Image:
Fetal alcohol syndrome testing expands
(Date:6/15/2016)... June 15, 2016 Transparency ... titled "Gesture Recognition Market by Application Market - Global Industry Analysis ... 2024". According to the report, the  global gesture recognition ... 2015 and is estimated to grow at a ... by 2024.  Increasing application of gesture ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) ... million US Dollar project, for the , Supply ... Enrolment, and IT Infrastructure , to ... implementation of Identity Management Solutions. Numerous renowned international vendors participated ... was selected for the most compliant and innovative ...
(Date:5/20/2016)... MINNEAPOLIS , May 20, 2016  VoiceIt ... technology partnership with VoicePass. By working ... user experience.  Because VoiceIt and VoicePass take slightly ... two engines increases both security and usability. ... expressed excitement about this new partnership. ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... , ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension ... are higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... bottom of the cuvette holder. , FireflySci has developed several Agilent flow cell ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
Breaking Biology Technology: